IMM 1.72% 29.5¢ immutep limited

Lu888This process began a long time ago. The FDA are happy...

  1. 4,906 Posts.
    lightbulb Created with Sketch. 343
    Lu888
    This process began a long time ago. The FDA are happy starting CVac with 2b/3 trial,not a phase2 followed by a phase 3 trial. This is a lot less expensive and quicker to market, it's not a flash in the pan.

    Document date: Thu 09 May 2002
    Published: Thu 09 May 2002 12:21:17
    Document No: 215987

    "This technology relies on boosting a patient'rial followed bymune system to fight
    cancer. The novel approach involves extracting patients' blood cells,
    manipulating the immune cells and reinjecting the cells into the
    patient. This technology has been developed by scientists at the
    Austin Research Institute (ARI) over the last 10 years and has been
    the subject of intense research."

    http://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=text&issuerId=1045&announcementId=482378
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
0.005(1.72%)
Mkt cap ! $428.5M
Open High Low Value Volume
28.5¢ 30.5¢ 28.5¢ $469.8K 1.579M

Buyers (Bids)

No. Vol. Price($)
9 297652 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 7500 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.